Characterization of Bioactive Components in Edible Algae II
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (12 November 2021) | Viewed by 25966
Special Issue Editor
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
At this current point in human history (year 2020), global society faces a Herculean challenge in combating the pandemic of Covid-19. Presently, there is no vaccine for immunization against this virus, but various seaweeds have specific characteristics that may provide a glimpse into potential solutions to this global health problem in the near future, and may possibly arm us for any future such pandemics. Seaweeds are already used in many products and for different purposes, from food products to medicine. They are a natural resource that can provide several compounds with beneficial bioactivities such as antiviral, anti-cholesterol, antioxidant, anti-inflammatory, and anti-aging effects, among others. The high variability of compounds synthetized by seaweed is an outcome of the adverse conditions to which they are exposed in their natural habitats.
Nowadays, all groups of macroalgae are gaining the attention of the scientific community because of the bioactive substances they produce. Several macroalgae products have exceptional properties with nutraceutical, pharmacological, and biomedical significance. The main compounds studied are polysaccharides, phenols, pigments, and fatty acids. Polysaccharides are the most exploited molecules, which are already widely used in various industries, and are, presently, entering into more advanced applications from a therapeutic point of view.
Prof. Dr. Leonel Pereira
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.